your limit has been reached. plz Donate us to allow your ip full access, Email: sshnevis@outlook.com
Uptodate Reference Title
Clopidogrel improves outcome in an acute coronary syndrome
Clopidogrel improves outcome in an acute coronary syndrome
In the CURE trial, 12,562 patients with an acute coronary syndrome were randomly assigned to clopidogrel or placebo in combination with aspirin. After a one-year follow-up, the incidence of the first primary outcome (cardiovascular death, nonfatal myocardial infarction, or stroke) was significantly lower with clopidogrel (9.3 versus 11.4 percent for placebo). This benefit was largely due to fewer nonfatal infarctions.
Data from Yusuf S, Zhao F, Mehta HR, et al. N Engl J Med 2001; 345:494